무료 / 오픈소스Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
Cradle는 월간 방문 16,993, 전월 대비 성장률 -22.3%, 가격 문의 가격 모델을 기록합니다. Synthace는 월간 방문 8,817, 성장률 +17.6%, 가격 문의 가격 모델을 기록합니다.

Synthace is a cloud software platform that helps life-science R&D teams design multivariate experiments, automate their execution across lab hardware, and capture the results as structured, contextualized data. It combines design-of-experiments (DOE) tooling with instrument and dispenser integrations so biologists can run richer experiments without writing code or rebuilding their automation stack.
| 항목 / 지표 | ![]() | ![]() |
|---|---|---|
| 공식 도메인 | cradle.bio | synthace.com |
| 가격 모델 | 가격 문의 | 가격 문의 |
| 월간 방문 수 | 1.7만 (16,993) | 8.82천 (8,817) |
| 전월 대비 트래픽 변화량 | -4.88천 (-22.3%) | +1.32천 (+17.6%) |
| 주요 시장 및 점유율 | 🇳🇱 네덜란드 (47.6%) | 🇺🇸 미국 (62.5%) |
| 월 직접 방문 수 | 6.21천 | 2.66천 |
| 사용자 평점 | 4.5 | 4.2 |
| 지원 플랫폼 | 웹사이트 | 웹사이트 |

AI로 더 나은 단백질을 더 빠르게
타깃이나 자체 서열에서 시작해, 고객 데이터와 도메인 지식을 반영한 최적화 후보 플레이트를 Cradle이 설계합니다.
효능, 개발 가능성, 제조 가능성을 순차가 아니라 동시에 개선해 목표 프로파일까지 걸리는 시간을 단축합니다.
각 라운드가 이전 라운드 결과를 반영해 실험 데이터가 캠페인 전반에 누적되고, 과거 실패도 자산이 됩니다.
웹 앱의 모든 기능이 API로 제공되어 계산 팀이 스크립트를 작성하고 기존 파이프라인에 연결할 수 있습니다.

Synthace is a cloud software platform that helps life-science R&D teams design multivariate experiments, automate their execution across lab hardware, and capture the results as structured, contextualized data. It combines design-of-experiments (DOE) tooling with instrument and dispenser integrations so biologists can run richer experiments without writing code or rebuilding their automation stack.
Build multifactorial experiments in the browser, choosing factors, ranges, and responses, and let the platform generate a statistically sound design that fits the number of runs you can afford.
Translate designed experiments into automated instructions for liquid handlers and dispensers already in your lab, reducing manual pipetting work and improving reproducibility.
Every run is captured with the parameters, protocol, and conditions that produced it, so results arrive as analysis-ready datasets instead of fragmented files needing manual alignment.
Field application scientists help teams run initial projects, and DOE and automation courses build in-house capability so scientists become self-sufficient over time.
무료 / 오픈소스Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.

무료 / 오픈소스Uizard is an AI-assisted UI/UX design platform that turns text prompts, screenshots, and hand-drawn sketches into editable, multi-screen prototypes for web, mobile, tablet, and desktop products.
무료 / 오픈소스Uizard is an AI-assisted UI/UX design platform that turns text prompts, screenshots, and hand-drawn sketches into editable, multi-screen prototypes for web, mobile, tablet, and desktop products.

데이터로 심장병을 측정하고 예측하고 예방하세요

무료 / 오픈소스Quilter is an AI platform for electronics design that automates PCB placement and routing. Upload a prepared design, get hundreds of physics-validated candidate layouts in hours, review them in your ECAD tool, and iterate until the board is fabrication-ready.
무료 / 오픈소스Quilter is an AI platform for electronics design that automates PCB placement and routing. Upload a prepared design, get hundreds of physics-validated candidate layouts in hours, review them in your ECAD tool, and iterate until the board is fabrication-ready.
무료 / 오픈소스바로 쓰는 데이터베이스 설계, 샘플 데이터, AI 스키마 도구
AI, 자동화, 데이터 품질 관리를 하나로 묶은 애자일 MROps 플랫폼

무료 / 오픈소스자체 컴퓨터와 브라우저를 가진 협업 AI 에이전트로 앱·리서치·문서·디자인까지
무료 / 오픈소스자체 컴퓨터와 브라우저를 가진 협업 AI 에이전트로 앱·리서치·문서·디자인까지

Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.
Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.